Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Guy

Showing results (551-560 of 587) with videos related to

Pageof 59
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 18, 2014
Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolaseJohn M Keith, William M Jones, Joan M Pierce, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|August 17, 2006
Designing systematic conservation assessments that promote effective implementation: best practice from South AfricaAndrew T Knight, Amanda Driver, Richard M Cowling, et al.
The Medical Journal of Australia|February 19, 2019
Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004-2015Hamish McManus, Denton Callander, Basil Donovan, et al.
Endoscopy|June 1, 2021
Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) GuidelineKonstantinos Triantafyllou, Paraskevas Gkolfakis, Ian M Gralnek, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2016
The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitorsJohn M Keith, Mark S Tichenor, Richard L Apodaca, et al.
The Lancet. HIV|February 22, 2017
Effect of availability of HIV self-testing on HIV testing frequency in gay and bisexual men at high risk of infection (FORTH): a waiting-list randomised controlled trialMuhammad S Jamil, Garrett Prestage, Christopher K Fairley, et al.
Sexually Transmitted Infections|May 12, 2018
Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluationLouise M Causer, Rebecca J Guy, Sepehr N Tabrizi, et al.
The Medical Journal of Australia|July 12, 2022
The acceptability and usability of two HIV self-test kits among men who have sex with men: a randomised crossover trialDana Yl Lee, Jason J Ong, Kirsty Smith, et al.
BMC Public Health|November 10, 2021
Sustaining success: a qualitative study of gay and bisexual men's experiences and perceptions of HIV self-testing in a randomized controlled trialYe Zhang, Rebecca J Guy, Kirsty S Smith, et al.
Journal of Medicinal Chemistry|March 18, 2005
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonistDevin M Swanson, Adrienne E Dubin, Chandra Shah, et al.
Pageof 59

Showing results (551-560 of 587) with videos related to

Sort By:
Pageof 59
Bioorganic & Medicinal Chemistry Letters|January 18, 2014
Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolaseJohn M Keith, William M Jones, Joan M Pierce, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|August 17, 2006
Designing systematic conservation assessments that promote effective implementation: best practice from South AfricaAndrew T Knight, Amanda Driver, Richard M Cowling, et al.
The Medical Journal of Australia|February 19, 2019
Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004-2015Hamish McManus, Denton Callander, Basil Donovan, et al.
Endoscopy|June 1, 2021
Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) GuidelineKonstantinos Triantafyllou, Paraskevas Gkolfakis, Ian M Gralnek, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2016
The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitorsJohn M Keith, Mark S Tichenor, Richard L Apodaca, et al.
The Lancet. HIV|February 22, 2017
Effect of availability of HIV self-testing on HIV testing frequency in gay and bisexual men at high risk of infection (FORTH): a waiting-list randomised controlled trialMuhammad S Jamil, Garrett Prestage, Christopher K Fairley, et al.
Sexually Transmitted Infections|May 12, 2018
Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluationLouise M Causer, Rebecca J Guy, Sepehr N Tabrizi, et al.
The Medical Journal of Australia|July 12, 2022
The acceptability and usability of two HIV self-test kits among men who have sex with men: a randomised crossover trialDana Yl Lee, Jason J Ong, Kirsty Smith, et al.
BMC Public Health|November 10, 2021
Sustaining success: a qualitative study of gay and bisexual men's experiences and perceptions of HIV self-testing in a randomized controlled trialYe Zhang, Rebecca J Guy, Kirsty S Smith, et al.
Journal of Medicinal Chemistry|March 18, 2005
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonistDevin M Swanson, Adrienne E Dubin, Chandra Shah, et al.
Pageof 59